| Literature DB >> 27058643 |
Oksana Bilyk1, Andriy Luzhetskyy2.
Abstract
Actinomycetes are known to produce over two-thirds of all known secondary metabolites. We review here recent progress in the metabolic engineering of streptomycetes for natural product biosynthesis. Several examples of the yield improvement of polyketides (mithramycin and tylactone) and non-ribosomal peptides (balhimycin and daptomycin) demonstrate the power of precursor supply engineering. Another example is the manipulation of a regulatory network for increased production of nystatin and teicoplanin. The second part highlights new approaches in the derivatization of natural products via combination of mutasynthesis and genomic engineering. Copyright ÂEntities:
Mesh:
Substances:
Year: 2016 PMID: 27058643 DOI: 10.1016/j.copbio.2016.03.008
Source DB: PubMed Journal: Curr Opin Biotechnol ISSN: 0958-1669 Impact factor: 9.740